Michael Moran, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Metabolism Lung Cancer Iron Homeostasis Proteomics Molecular Genetics Iron-Sulfur Cluster Krebs Cycle Mass Spectrometry

Latest papers

Top-Down Determination of Black Carbon Emissions from Oil Sand Facilities in Alberta, Canada Using Aircraft Measurements.
Environmental science & technology · 2020
Extracellular phosphorylation drives the formation of neuronal circuitry.
Nature chemical biology · 2019

All 2 publications

Latest funding

Metabolism-driven cancer phenotypes and therapeutic vulnerabilities
CIHR · 2024 · Nominated PI
$963,900
Mechanism of cell transformation by aconitase
CIHR · 2023 · Nominated PI
$100,000
Regulation of diverse cellular functions by iron
NSERC · 2023 · Principal investigator
$78,000

All 15 grants and awards

2 publications.

01

Top-Down Determination of Black Carbon Emissions from Oil Sand Facilities in Alberta, Canada Using Aircraft Measurements.

Cheng Y, Li SM, Liggio J, Gordon M, Darlington A, Zheng Q, Moran M, Liu P, Wolde M

Environmental science & technology2020

DOI: 10.1021/acs.est.9b05522 PMID: 31834792

02

Extracellular phosphorylation drives the formation of neuronal circuitry.

Harada H, Farhani N, Wang XF, Sugita S, Charish J, Attisano L, Moran M, Cloutier JF, Reber M, Bremner R, Monnier PP

Nature chemical biology2019

DOI: 10.1038/s41589-019-0345-z PMID: 31451763

Metabolism-driven cancer phenotypes and therapeutic vulnerabilities

Nominated PICIHR2024Project Grant

Principal investigators: Moran, Michael F

Keywords: Iron Homeostasis; Lung Cancer; Metabolism; Molecular Genetics; Proteomics

$963,900

Mechanism of cell transformation by aconitase

Nominated PICIHR2023Project Grant - Priority Announcement: Cancer Research

Principal investigators: Moran, Michael F

Keywords: Iron-Sulfur Cluster; Krebs Cycle; Mass Spectrometry; Metabolism; Patient-Derived Xenograft

$100,000

Regulation of diverse cellular functions by iron

Principal investigatorNSERC2023Discovery Grants Program - Individual

Principal investigators: Moran, Michael

Keywords: iron-sulfur; mass spectrometry; metabolism; mitochondrion; protein-protein interactions; proteomics; signal transduction; subcellular organelle

$78,000

An ACO2-Iron Axis in Aggressive Lung Cancer

Nominated PICIHR2022Project Grant - Priority Announcement: Cancer Research

Principal investigators: Moran, Michael F

Keywords: Cancer; Iron Homeostasis; Metabolism; Proteomics

$100,000

Organoids to guide Post-resistance Therapy In driver MutAted Lung cancers (OPTIMAL)

Co-investigatorCIHR2020Project Grant

Principal investigators: Liu, Geoffrey

Keywords: Anaplastic Lymphoma Kinase Rearrangements; Drug Resistance Mechanisms; Drug Sensitivity Screening; Epidermal Growth Factor Receptor; Epigenetics; Genomics; Non-Small Cell Lung Cancer; Patient-Derived Organoids; Ros1 Rearrangements; Trascriptomics

$1,147,500

Targeting Relapsed Metastatic Neuroblastoma

Co-investigatorCIHR2018Project Grant

Principal investigators: Irwin, Meredith; Kaplan, David R

Keywords: Drug Discovery; Metastasis; Neuroblastoma; Paediatric Cancer; Signal Transduction

$929,475

Integrated Nanotechnology and Biomedical Sciences Laboratory

Co-investigatorCIHR2017Foundation Grant

Principal investigators: Chan, Warren C

Keywords: Cancer; Nanotechnology

$2,100,092

Cancer target discovery and validation in the stromal phospho-proteome

Nominated PICIHR2016Project Grant

Principal investigators: Moran, Michael F; Moffat, Jason; Sidhu, Sachdev S

Keywords: Lung Cancer; Phosphorylation

$860,064

Regulation of EGF receptor trafficking fate by phosphorylation and Odin

Principal investigatorNSERC2016Discovery Grants Program - Individual

Principal investigators: Moran, Michael

$228,000

Multimodal strategy to identify novel diagnostic and therapeutic targets in lung and pancreatic cancer

Co-investigatorCIHR2015Foundation Grant

Principal investigators: Tsao, Ming-Sound

Keywords: Antibody; Bioinformatics; Cell Line; Microarray; Molecular Imaging; Molecular Pathology; Next Generation Sequencing; Patient Primary Tumor; Primary Xenograft; Shrna Screening

$3,738,542

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Department of Molecular Genetics
Neurology and Neurosurgery
Department of Biochemistry
Lunenfeld-Tanenbaum Research Institute
Other

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Rod Bremner

Lunenfeld-Tanenbaum Research Institute

1 shared papers, latest 2019

Peter Liu

Faculty

1 shared papers, latest 2020

Michael Reber

Faculty

1 shared papers, latest 2019

Jean-Francois Cloutier

Neurology and Neurosurgery

1 shared papers, latest 2019

Shuzo Sugita

Faculty

1 shared papers, latest 2019

Liliana Attisano

Department of Biochemistry

1 shared papers, latest 2019

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Metabolism Dear Professor Moran, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Top-Down Determination of Black Carbon Emissions from Oil Sand Facilities in Alberta, Canada Using Aircraft Measurements." (2020), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Metabolism-driven cancer phenotypes and therapeutic vulnerabilities" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]